Laurent Bogdanik
Overview
Explore the profile of Laurent Bogdanik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
573
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sullivan J, Bagnell A, Alevy J, Avila E, Mihaljevic L, Saavedra-Rivera P, et al.
Sci Transl Med
. 2024 May;
16(748):eadk1358.
PMID: 38776392
Blood-CNS barrier disruption is a hallmark of numerous neurological disorders, yet whether barrier breakdown is sufficient to trigger neurodegenerative disease remains unresolved. Therapeutic strategies to mitigate barrier hyperpermeability are also...
2.
Presa M, Bailey R, Davis C, Murphy T, Cook J, Walls R, et al.
J Clin Invest
. 2021 Apr;
131(11).
PMID: 33878035
Charcot-Marie-Tooth disease type 4J (CMT4J) is caused by recessive, loss-of-function mutations in FIG4, encoding a phosphoinositol(3,5)P2-phosphatase. CMT4J patients have both neuron loss and demyelination in the peripheral nervous system, with...
3.
Dupont C, Novak K, Denman K, Myers J, Sullivan J, Walker 2nd P, et al.
Ann Neurol
. 2020 May;
88(2):297-308.
PMID: 32418267
Objective: Myotonia is caused by involuntary firing of skeletal muscle action potentials and causes debilitating stiffness. Current treatments are insufficiently efficacious and associated with side effects. Myotonia can be triggered...
4.
Krishnan V, Aartsma-Rus A, Overzier M, Lutz C, Bogdanik L, Grounds M
Mol Cell Neurosci
. 2020 Apr;
105:103484.
PMID: 32240725
This study investigates changes with respect to increasing protein levels in dystrophic nerves of two mdx mouse models of Duchenne muscular dystrophy (DMD). We propose that these nerve changes result...
5.
Gordish-Dressman H, Willmann R, Dalle Pazze L, Kreibich A, van Putten M, Heydemann A, et al.
J Neuromuscul Dis
. 2018 Sep;
5(4):407-417.
PMID: 30198876
A new line of dystrophic mdx mice on the DBA/2J (D2) background has emerged as a candidate to study the efficacy of therapeutic approaches for Duchenne muscular dystrophy (DMD). These...
6.
Willmann R, Gordish-Dressman H, Meinen S, Ruegg M, Yu Q, Nagaraju K, et al.
J Neuromuscul Dis
. 2017 May;
4(2):115-126.
PMID: 28550268
Laminin-α2 related Congenital Muscular Dystrophy (LAMA2-CMD) is a progressive muscle disease caused by partial or complete deficiency of laminin-211, a skeletal muscle extracellular matrix protein. In the last decade, basic...
7.
ORourke J, Bogdanik L, Muhammad A, Gendron T, Kim K, Austin A, et al.
Neuron
. 2015 Dec;
88(5):892-901.
PMID: 26637796
Noncoding expansions of a hexanucleotide repeat (GGGGCC) in the C9orf72 gene are the most common cause of familial amyotrophic lateral sclerosis and frontotemporal dementia. Here we report transgenic mice carrying...
8.
Coley W, Bogdanik L, Vila M, Yu Q, Van der Meulen J, Rayavarapu S, et al.
Hum Mol Genet
. 2015 Nov;
25(1):130-45.
PMID: 26566673
Genetic background significantly affects phenotype in multiple mouse models of human diseases, including muscular dystrophy. This phenotypic variability is partly attributed to genetic modifiers that regulate the disease process. Studies...
9.
Fairfield H, Srivastava A, Ananda G, Liu R, Kircher M, Lakshminarayana A, et al.
Genome Res
. 2015 Apr;
25(7):948-57.
PMID: 25917818
Spontaneously arising mouse mutations have served as the foundation for understanding gene function for more than 100 years. We have used exome sequencing in an effort to identify the causative...
10.
Osborne M, Gomez D, Feng Z, McEwen C, Beltran J, Cirillo K, et al.
Hum Mol Genet
. 2012 Jul;
21(20):4431-47.
PMID: 22802075
A number of mouse models for spinal muscular atrophy (SMA) have been genetically engineered to recapitulate the severity of human SMA by using a targeted null mutation at the mouse...